Sexual Dysfunction Evaluation in Candidal Balanoposthitis: A Single Centred Observational Study.
Dhillon SS, Dhaliwal R, Dev K, Mehmi N.
J Family Reprod Health. 2023 Mar;17(1):8-13. doi: 10.18502/jfrh.v17i1.11971.
Diabetes and balanoposthitis.
Kalra S, Chawla A.
J Pak Med Assoc. 2016 Aug;66(8):1039-41.
[Balanoposthitis in the clinical practice of a urologist and dermatovenereologist: an interdisciplinary problem].
Khryanin A A, Sokolovskaya A V, Bocharova V K.
Urologiia. 2023 Dec;(6):152-157.
Balanitis and balanoposthitis: a review.
Edwards S.
Genitourin Med. 1996 Jun;72(3):155-9. doi: 10.1136/sti.72.3.155.
Morphological Patterns of Balanoposthitis and their Correlation with Final Etiological Diagnosis.
Jain M, Ansari F, Agarwal N, Mittal AK.
Indian Dermatol Online J. 2023 Feb 23;14(2):187-194. doi: 10.4103/idoj.idoj_197_22. eCollection 2023 Mar-Apr.
"Candidal balanoposthitis in male".
Chakraborty AK, Datta AK.
Indian J Dermatol. 1979 Oct;24(5):23-30.
Severe candidal balanoposthitis on concurrent treatment with secukinumab and the antidiabetic agent empagliflozin (sodium-glucose cotransporter 2 inhibitor - SGLT2-inhibitor).
Moldenhauer I, Pliquett RU, Kreft B, Sunderkötter C.
J Dtsch Dermatol Ges. 2019 Apr;17(4):456-458. doi: 10.1111/ddg.13807. Epub 2019 Mar 15.
Gardnerella vaginalis-associated balanoposthitis.
Burdge DR, Bowie WR, Chow AW.
Sex Transm Dis. 1986 Jul-Sep;13(3):159-62. doi: 10.1097/00007435-198607000-00009.
A descriptive study of the clinical and etiological profile of balanoposthitis.
Jegadish N, Fernandes SD, Narasimhan M, Ramachandran R.
J Family Med Prim Care. 2021 Jun;10(6):2265-2271. doi: 10.4103/jfmpc.jfmpc_2467_20. Epub 2021 Jul 2.
Expression of interleukin-2 in Candidal balanoposthitis and its clinical significance.
Chen J, Zhou YX, Jin XD, Chen SW.
Chin Med J (Engl). 2011 Sep;124(17):2776-8.
